Since carvedilol and nebivolol are prescribed and deemed to be clinically safe (despite some anti-hERG activity), they may offer an alternative to NPS-2143 and may be worthy of further investigation in AP. The gene discussed is KCNH2; the disease is alkaline phosphatase measurement.